Radiopharm Theranostics Ltd (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Radiopharm Theranostics Ltd - ADR: Is Infosys Ltd. worth buying?
Item: Radiopharm Theranostics Ltd - ADR
Rating: 0.97908325
Author: Trendlyne DVM scores

about

Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pr...

5.05 0.17 (3.48%)

68.92% Fall from 52W High

26,115

XNAS Volume

XNAS 22 Jan, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Radiopharm Theranostics Ltd (ADR) is on 30 Jan 2026 for the purpose of Radiopharm Theranostics Ltd Second Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

8.8 / 100

Technically Bearish

30.3 / 100

1Yr Price target upside is 253%

5 analysts

Radiopharm Theranostics Ltd (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..